CLINICAL_TRIALS
trial_result
· 2020-08-06
Clinical Trial Update: A Treatment Study of Mucopolysaccharidosis Type IIIB [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial in mucopolysaccharidosis type IIIB (MPS IIIB) completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Allievex Corporation | Conditions: MPS III B, Mucopolysaccharidosis Type IIIB | Phase 1, Phase 2 | Status: COMPLETED